David Hamer in Pasadena, Texas

Home Texas Pasadena

David Hamer has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 5010 Crenshaw Rd in Pasadena, Texas. There are 3 additional office locations for David Hamer that can be viewed towards the end of their profile.

They're a part of the: David Hamer Md Pa medical group which has around 8 members. You can call their office at 832-399-0400 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended New York University School Of Medicine and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David S Hamer Office Phone and Directions

David Hamer
David Hamer Md Pa
5010 Crenshaw Rd
Pasadena, Texas 77505
832-399-0400

Patient Ratings
Please rate your experience with David Hamer below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 832-399-0400

Enter a starting address:

Healthcare Info for David Hamer

Medical School: New York University School Of Medicine
Graduation Year: 1988
The Primary Medical Specialty for David Hamer is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 36
PAC (PECOS ID)#: 3375436983
NPI #: 1336176429
NPI Created On: 06/26/2006
NPI Last Updated Listed as: 09/22/2023
Primary Taxonomy Code: 207RC0000X
License Number:
J6126
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Community Health Choice
Molina Marketplace
Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
Blood test, clotting time
Routine ekg using at least 12 leads including interpretation and report
Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
Evaluation, testing, and programming adjustment of permanent dual lead pacemaker system with physician analysis, review, and report
Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
Remote evaluations of defibrillator up to 90 days with analysis, review and report
Remote evaluations of single, dual, or multiple lead pacemaker system or implantable defibrillator system with technician review, support and distribution of results, up to 90 days
Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days
Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125381

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125383

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125385

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125387

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125389

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788125391

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794730737

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794730741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTI-INFECTIVE

Name of Drug #1: DALVANCE

Open Associated Drug #1: 57970-100-01

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802082585

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Additional Office Locations

1. David Hamer Md Pa
530 Orchard St
Webster, TX 77598
Group Members: 8

Phone: 832-399-0400

Enter a starting address:

2. Clear Lake Specialties Pa
5010 Crenshaw Rd
Pasadena, TX 77505
Suite 110
Group Members: 76

Enter a starting address:

3. Clear Lake Specialties Pa
530 Orchard St
Webster, TX 77598
Group Members: 76

Enter a starting address:

Cardiovascular Disease (cardiology) Professionals in Pasadena

1.
Gerard Abreo

5010 Crenshaw Rd
Pasadena, TX
David Hamer Md Pa

2.
Gerard Abreo

5010 Crenshaw Rd
Pasadena, TX
Clear Lake Specialties Pa

3.
Anna Harkins JR.

5010 Crenshaw Rd
Pasadena, TX
David Hamer Md Pa

4.
Anna Harkins JR.

5010 Crenshaw Rd
Pasadena, TX
Clear Lake Specialties Pa

5.
Mary Mercado MD

5010 Crenshaw Rd
Pasadena, TX
David Hamer Md Pa

6.
Mary Mercado MD

5010 Crenshaw Rd
Pasadena, TX
Clear Lake Specialties Pa

Providers in David Hamer Md Pa

1.Gerard Abreo

5010 Crenshaw Rd
Pasadena Tx 77505-4614
David Hamer Md Pa
Cardiovascular Disease (cardiology)

2.Gerard Abreo

530 Orchard St
Webster Tx 77598-4110
David Hamer Md Pa
Cardiovascular Disease (cardiology)

3.Ahmad Al-taweel

5010 Crenshaw Rd
Pasadena Tx 77505-4614
David Hamer Md Pa
Cardiovascular Disease (cardiology)

4.Ahmad Al-taweel

530 Orchard St
Webster Tx 77598-4110
David Hamer Md Pa
Cardiovascular Disease (cardiology)

5.Molham Aldeiri

5010 Crenshaw Rd
Pasadena Tx 77505-4614
David Hamer Md Pa
Cardiovascular Disease (cardiology)

6.Molham Aldeiri

530 Orchard St
Webster Tx 77598-4110
David Hamer Md Pa
Cardiovascular Disease (cardiology)

View all 8 members of David Hamer Md Pa medical group